Welcome to our dedicated page for Beneficient-A SEC filings (Ticker: BENF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Beneficient’s alternative-asset business model packs pages of specialized terminology—TEFFI trust structures, AltAccess platform metrics, and loan-to-value disclosures—into every SEC filing. Finding where management discusses liquidity risk or how Ben Custody books revenue can take hours. Stock Titan solves this by delivering AI-powered summaries that turn Beneficient SEC filings into clear insights you can act on.
Whether you need the Beneficient annual report 10-K simplified, the latest Beneficient quarterly earnings report 10-Q filing, or a sudden Beneficient 8-K material events explained, our platform updates in real time as each document hits EDGAR. Investors tracking Beneficient insider trading Form 4 transactions can set instant alerts and view Beneficient Form 4 insider transactions real-time alongside easy-to-read charts. Our AI also maps pages that detail TEFFI capital ratios, technology spending, and segment revenue, so understanding Beneficient SEC documents with AI feels effortless.
Use this page to:
- Scan Beneficient earnings report filing analysis for cash-flow timing across Ben Liquidity and Ben Custody
- Review the Beneficient proxy statement executive compensation to gauge incentives driving growth
- Monitor Beneficient executive stock transactions Form 4 before major announcements
All filing types—10-K, 10-Q, 8-K, S-1, DEF 14A and more—are covered, timestamped, and linked to concise AI commentary. No more hunting through PDFs; get Beneficient SEC filings explained simply and make informed decisions with confidence.
Beneficient (BENF) announced the immediate resignation of Brad Heppner from his positions as CEO, Board Chairman, and Director on June 19, 2025. The resignation came after Heppner refused to participate in a formal interview requested by the Audit Committee regarding documents and information concerning his relationship with a related entity provided to auditors in 2019.
Key developments include:
- Heppner rejected proposals to transfer certain rights of Beneficient Holdings Inc (BHI) under a stockholders agreement
- He declined to convert Preferred Series A Subclass 0 Unit Accounts of BCH held by BHI to meet Nasdaq listing requirements
- Through counsel, Heppner expressed belief that "the only viable course for the Company is an orderly wind down of operations"
- Prior to resignation, Heppner served on multiple board committees including Nominating, Community Reinvestment, Executive, Enterprise Risk, and Credit Committees
The stock traded at $0.2770 per share and warrants at $0.0069 as of June 24, 2025. The company remains classified as an emerging growth company and controlled company under Nasdaq rules.
Beneficient (Nasdaq:BENF) filed an 8-K reporting the immediate resignation of CEO & Chairman Brad Heppner on 19-Jun-2025.
The departure followed Heppner’s refusal to participate in a formal Audit Committee interview concerning 2019 related-party documentation. Counsel’s email (Ex. 99.1) shows disagreement with possible voluntary disclosure unless Heppner transferred certain Beneficient Holdings Inc. rights and converted preferred units to strengthen stockholders’ equity for Nasdaq listing compliance.
No successor or severance terms were announced. Heppner also vacates five key board committees, removing leadership over Nominating, Community Reinvestment, Executive, Enterprise Risk and Credit functions.
- Material event: abrupt CEO/Chair resignation
- Governance risk: dispute over audit cooperation and disclosure
- Listing risk: unresolved equity conversion may jeopardize Nasdaq requirements
Beneficient (NASDAQ:BENF) filed an 8-K announcing the closure of a primary capital transaction through its subsidiary on June 17, 2025. The company issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund valued at $1.91 million.
The Series B-8 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3397 per share, subject to monthly resets and a floor price of $0.2548. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion. The preferred shares rank pari passu with common stock for dividends and liquidation rights.
Beneficient (NASDAQ:BENF) filed an 8-K announcing the closing of a significant equity transaction on June 17, 2025. The company issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in exchange for acquiring a limited partner interest in an investment fund valued at $1.91 million.
The Series B-8 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3397 per share, subject to monthly resets and a floor price of $0.2548. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion. The preferred shares will automatically convert on specific trigger events, including the fifth anniversary of issuance.
FAQ
What is the current stock price of Beneficient-A (BENF)?
What is the market cap of Beneficient-A (BENF)?
What is Beneficient's core business?
Which market segments does Beneficient serve?
How does Beneficient enhance liquidity for alternative assets?
What role does technology play in Beneficient's operations?
How does the company ensure regulatory compliance?
What differentiates Beneficient from its competitors?
What types of assets does Beneficient's platform support?
How does Beneficient promote transparency in its operations?
